LAMP2a is another protein proposed in the PD-GWAS as a candidate risk factor for sporadic PD [17]; its levels were indeed found to be reduced in the substantia nigra and amygdala of PD cases at a level shown to be sufficient to impair CMA and increase the half-life of α-synuclein [22]. Here, SNCA is linked to Parkinson disease.